Skip to content

Invitation


On behalf of the Epilepsy Society of Australia, we have great pleasure in inviting you to submit an abstract for 35th Annual Scientific Meeting, to be held in Hobart, 2nd – 4th November 2021.
Abstracts are invited for platform and poster presentations on all aspects of clinical, basic science or allied health studies of epilepsy. We particularly encourage young or early researchers in epilepsy. If you wish to submit an abstract for consideration, you must also intend to register for the meeting.

The meeting we hope will mark a return to the value and camaraderie of a face-to-face meeting, although online attendance will also be an option. The major themes this year will be epilepsy co-morbidities, epilepsy genomics in the post-Mendelian era, and psychogenic non-epileptic seizures. Although we do not have the opportunity to invite overseas speakers, we will showcase our own internationally known researchers, including Professors Ingrid Scheffer, Patrick Kwan, and Graeme Jackson, among others.

We look forward to welcoming 200 or more delegates from around Australia and hopefully New Zealand, including trainees, practising neurologists, technologists, scientists, nurses and allied health professional, for the much missed opportunity to share knowledge and experiences with other professionals in epilepsy.

The 2021 meeting will be held at the Hotel Grand Chancellor in Hobart, with views and easy access to Hobart’s historic waterfront.

We look forward to receiving your abstracts and meeting again in November in Hobart.

Dean Jones and Tyson Ware
Co-Chairs, ESA Annual Scientific Meeting Committee

and

Terence O’Brien
ESA President

Abstracts Submission Guidelines

The SPC reserves the right to decide the format of presentation on the basis of time and space available.
Abstracts will not be accepted if they have been previously published as a full paper.
Abstracts will not be accepted if they have been presented elsewhere more than one year before the meeting date.
A condition of acceptance is that at least one author presents at the ASM.
Abstracts are to be provided in English.

Types of Presentations
Platform (Oral) Presentation - If your abstract is accepted as a platform presentation you will be allocated a session (time to be advised) within the program.
Poster Presentation - If your abstract is accepted as a poster, you will be required to produce a poster which follows the poster guidelines.

Format for Abstracts
The body of the abstract (other than case reports) 
should be structured with Objectives, Methods, Results and Conclusions. Any abbreviations should be defined where first mentioned. Abstracts will be published as submitted without any modification.

Abstracts should be a summary of the paper and must not exceed 300 words.
Do not include titles or degrees.
Check spelling and grammar.
Present sufficient data to support conclusions – it is unsatisfactory to use statements such as “data will be presented” or “results will be discussed”.
Failure to observe these requirements will exclude the abstract from consideration.

Registration
All presenters must register to attend the ASM and are responsible for their own travel, accommodation and registration expenses. A condition of acceptance is that at least one author presents at the ASM.

Abstract submission
On-line submission is the only method of receipt of abstracts.

You will be guided through the submission process and given instructions as required. You can save the submission at any time (even if incomplete) and return to it at a later stage, as long as it's prior to the submission deadline. You can withdraw your submission at any time too.

Confirmation of Receipt of Abstracts
Immediately following submission, you will receive an acknowledgment confirming receipt of your abstract, including a submission reference number. These details should be used if you wish to edit your abstract up to and no later than midnight AEST on Monday, 26th July 2021
.

No changes will be possible after this deadline.

Abstracts notifications will be sent out via email to abstract submitter by early September 2021.